IRIS
MARONGIU, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.881
AS - Asia 1.808
EU - Europa 1.044
SA - Sud America 1.011
Continente sconosciuto - Info sul continente non disponibili 102
AF - Africa 67
OC - Oceania 5
Totale 6.918
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.774
BR - Brasile 853
SG - Singapore 773
IT - Italia 493
CN - Cina 323
HK - Hong Kong 258
VN - Vietnam 187
DE - Germania 144
FR - Francia 93
AR - Argentina 59
GB - Regno Unito 59
FI - Finlandia 58
CA - Canada 40
IN - India 38
MX - Messico 35
TR - Turchia 34
UA - Ucraina 32
BD - Bangladesh 31
NL - Olanda 28
RU - Federazione Russa 26
IQ - Iraq 25
VE - Venezuela 23
ZA - Sudafrica 20
EC - Ecuador 19
CO - Colombia 18
KR - Corea 18
PL - Polonia 18
SE - Svezia 18
ES - Italia 15
PK - Pakistan 13
UZ - Uzbekistan 13
AT - Austria 12
JP - Giappone 12
CZ - Repubblica Ceca 11
AZ - Azerbaigian 10
BE - Belgio 10
CL - Cile 10
JM - Giamaica 10
ID - Indonesia 9
KE - Kenya 8
PY - Paraguay 8
IL - Israele 7
LT - Lituania 7
MY - Malesia 7
UY - Uruguay 7
BO - Bolivia 6
PE - Perù 6
TN - Tunisia 6
AU - Australia 5
CR - Costa Rica 5
DZ - Algeria 5
KZ - Kazakistan 5
MA - Marocco 5
NP - Nepal 5
SA - Arabia Saudita 5
CH - Svizzera 4
KG - Kirghizistan 4
PH - Filippine 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
GE - Georgia 3
GH - Ghana 3
HN - Honduras 3
OM - Oman 3
TH - Thailandia 3
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GT - Guatemala 2
GY - Guiana 2
IR - Iran 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
NI - Nicaragua 2
NO - Norvegia 2
PT - Portogallo 2
QA - Qatar 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CD - Congo 1
CG - Congo 1
CY - Cipro 1
ET - Etiopia 1
GM - Gambi 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
LU - Lussemburgo 1
LV - Lettonia 1
NE - Niger 1
NG - Nigeria 1
PA - Panama 1
Totale 6.810
Salva come PNG Salva come JPEG
Città #
Dallas 1.207
Singapore 417
San Jose 316
Hong Kong 254
Ashburn 204
Beijing 128
Council Bluffs 86
Chandler 78
Columbus 74
Munich 71
Ho Chi Minh City 67
Lauterbourg 61
São Paulo 57
Los Angeles 54
Cagliari 51
New York 45
Hanoi 43
Shanghai 40
Belo Horizonte 33
Rome 33
Boardman 32
Santa Clara 32
Milan 28
Rio de Janeiro 28
Turku 26
Helsinki 25
Orem 22
Sassari 19
Florence 18
West Jordan 18
Bologna 17
Seoul 17
Brasília 16
Buenos Aires 16
Chicago 16
Frankfurt am Main 16
Warsaw 16
Atlanta 15
Denver 15
Montreal 15
Princeton 14
Brooklyn 13
Jacksonville 13
Johannesburg 13
Nuremberg 13
Recife 13
Stockholm 13
Tashkent 13
Alghero 12
Poplar 12
Ankara 11
Boston 11
Falkenstein 11
London 11
Manaus 11
Salvador 11
Baku 10
Campinas 10
Chennai 10
Düsseldorf 10
Guarulhos 10
Manchester 10
Mexico City 10
Tokyo 10
Baghdad 9
Curitiba 9
Goiânia 9
Guayaquil 9
Kingston 9
Seattle 9
Brussels 8
Buffalo 8
Nova Iguaçu 8
Ribeirão Preto 8
Romola 8
Santiago 8
Trento 8
Brno 7
Catania 7
Dhaka 7
Istanbul 7
Lappeenranta 7
Nairobi 7
Pelotas 7
The Dalles 7
Wilmington 7
Amsterdam 6
Ann Arbor 6
Anápolis 6
Dearborn 6
Fortaleza 6
Kuala Lumpur 6
Mumbai 6
Nanjing 6
Osasco 6
Phoenix 6
Rio Grande 6
Selargius 6
Shenzhen 6
Toronto 6
Totale 4.258
Salva come PNG Salva come JPEG
Nome #
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 346
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 334
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia 235
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 187
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 177
Cortical metabolic 18F-FDG PET assessment and striatal dopamine transporter SPECT imaging in suspected early neurodegenerative disorders with uncertain movement and cognitive symptoms 163
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 154
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 147
Qualitative (Q) and semiquantitative (SQ) brain 18FFDG PET analyses in primary progressive aphasia (PPA) variants 143
18F-FDG brain and whole body (WB) PET/CT in intracranial leptomeningeal carcinomatosis and in paraneoplastic neurologic syndromes 141
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 141
18F-FDG Brain PET/CT Metabolic Imaging in Patients with Suspected Autoimmune Encephalitis (AE) in the Early Stage: Can the Procedure Play a Complementary Diagnostic Role? 140
The prognostic role of baseline and post neoadjuvant chemotherapy [18F]FDG PET/CT in triple-negative breast cancer: preliminary results of TRINE-PET trial 139
131I-SPECT/CT usefulness in patients with Hashimoto’s thyroiditis (HT) coexistence with papillary thyroid carcinoma (PC) without risk factors at surgery followed in a long-term follow-up after thyroidectomy and radioiodine ablation 133
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study. 133
A multicenter 18F-FDG-PET/CT study in solitary pulmonary nodule: Qualitative and Semiquantitative parameters to predict the risk of malignancy 130
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 130
Breast-Specific Gamma Imaging: An Added Value in the Diagnosis of Breast Cancer, a Systematic Review 128
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 127
Qualitative and semiquantitative parameters in solitary pulmonary nodule: a multicenter 18F-FDG-PET/CT study 126
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease 119
Harmonization of multi-center data for preliminary investigation of cardiac MIBG scintigraphy in Parkinsonism (ITA-MIBG STUDY): a novel approach using phantom calibration with tube and bottle. 117
Large Italian Multicenter Study on Prognostic Value of Baselines Variables in mCRPC Patients Treated with 223RaCl2: Ten Years of Clinical Experience 115
Brain 123I-ioflupane SPECT and 18F-FDG PET combined use in movement and cognitive associated diseases of recent appearance 115
131I-SPECT/CT at the first radioiodine ablation and during follow-up in patients with differentiated thyroid carcinoma (DTC). 115
Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on 18F-FDG PET/CT and Automated Classifiers 113
131I-SPECT/CT after radioiodine therapy in patients with differentiated thyroid carcinoma 111
Pet-radiomics in lymphoma and multiple myeloma: update of current literature 109
Multi-centre data harmonisation applied to heart-to-mediastinum quantification in parkinsonism (ITA-MIBG): a cross-calibration phantom study with tube and bottle 109
Performance Analysis of Six Semi-Automated Tumour Delineation Methods on [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in Patients with Head and Neck Cancer 108
The prognostic role of [18F]FDG PET/CT for suspected recurrence or monitoring systemic treatment in triplenegative breast cancer: preliminary results of the TRINE-PET trial. 107
Radiomics analysis on PET/CT scans to discriminate malignant (adenocarcinoma) and benign pulmonary nodules 104
A multicenter study for the analysis of early onset Parkinson’s disease population: the role of 123I-FP-CIT and 123I-MIBG 104
Prognostic role of the risk factors in the follow-up of T1B-T2 papillary thyroid carcinoma (PC) 102
Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand? 101
123I-MIBG Cardiac Scintigraphy and Heart/Mediastinum Ratio in Neurodegenerative Disorders: Is Delayed Scan Really Necessary? 101
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study 100
The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up 99
Brain SPECT DAT imaging and 18F-FDG PET/CT combined use in the early stage of movement and cognitive associated neurodegenerative disorders 99
The role of routine 131I-SPECT/CT use in differentiated thyroid carcinoma (DTC) follow-up 96
Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy 95
Utility of shape and texture features from [18F]-FDG PET to predict cervical nodal status in patients with head & neck cancer 94
First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review 94
Evaluation of Bone Scan Index as a Prognostic Tool in Breast Cancer Patients with Bone Metastasis 94
18F-FDG PET/CT (PET) and serum neurodegenerative biomarkers (NB) in suspected cognitive disorders (CD): a preliminary study 93
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up 92
Radiomics Features from Positron Emission Tomography with [18F] Fluorodeoxyglucose Can Help Predict Cervical Nodal Status in Patients with Head and Neck Cancer 87
The prognostic role of baseline and post neoadjuvant chemotherapy [18F]FDG PET/CT in triple-negative breast cancer: preliminary results of the TRINE-PET trial 84
Qualitative and Semiquantitative Parameters of 18F-FDG-PET/CT as Predictors of Malignancy in Patients with Solitary Pulmonary Nodule 82
Prognostic role of minimal extrathyroidal tumor extension (mETE) in the follow-up of patients with papillary carcinoma (PC) unaffected by other risk factors. 81
Usefulness of PET/CT with 18F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study 78
Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer 71
Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson's Disease: A Multicenter Study 69
Radionuclide-based nanotechnologies in brain tumors: an updated overview 65
Long-term follow-up of patients thyroidectomized for thyroid papillary carcinoma (PC) with associated Graves’s disease (GD): a 131I-SPECT/CT diagnostic study 62
Artificial Intelligence in PET Imaging for Alzheimer’s Disease: A Narrative Review 41
The impact of [18F]FDG PET/CT in guiding the change of management of triple-negative breast cancer patients: a sub-analysis of the TRINE-PET trial 37
Diagnostic Accuracy of DaTQUANT® Versus BasGanV2™ for 123I-Ioflupane Brain SPECT: A Machine Learning-Based Differentiation of Parkinson’s Disease and Essential Tremor 25
SPECT-based radiomics in oncology: current evidence, technical challenges, and future directions 25
Machine learning for automated differentiation of parkinson’s disease and its mimics using ¹²³I-mIBG scintigraphy: insights from a multicentre real-world cohort (ITA-mIBG study) 23
Exploring the impact of Cabotegravir‐Rilpivirine long‐acting on weight gain, body composition and quality of life in adults living with HIV 23
From quantification to classification: comparative analysis of two software applications for machine learning–based prediction of early Parkinson’s disease using 123I-Ioflupane metrics 5
Totale 6.918
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.037
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.037
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 2 8 0 0 2 0 3 2 2 2 17
2022/2023153 8 14 2 35 8 30 4 15 26 2 6 3
2023/2024370 42 28 9 33 94 41 0 6 1 20 26 70
2024/20252.126 44 48 121 96 79 100 106 321 664 313 124 110
2025/20263.824 179 832 610 480 393 192 517 112 147 215 103 44
2026/2027300 80 220 0 0 0 0 0 0 0 0 0 0
Totale 6.918